A carregar...
Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
AIMS: Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). METHODS A...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083406/ https://ncbi.nlm.nih.gov/pubmed/31951680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12571 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|